Isothermal Nucleic Acid Amplification Technology Market Share, Size, Trends, Segments And Forecast By 2024-32


(MENAFN- IMARC Group) The latest report by IMARC Group, titled“ Isothermal Nucleic Acid Amplification Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032 “, The global isothermal nucleic acid amplification technology (INAAT) market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2032, exhibiting a growth rate (CAGR) of 10.8% during 2024-2032.

Isothermal nucleic acid amplification technology is a transforming technique used for amplifying DNA or RNA sequences at a constant temperature, unlike the traditional. It is gaining significant attention in the field of diagnostics, especially for the detection of infectious pathogens using nucleic acids as biomarkers. It offers simplicity, speed, and cost-effectiveness, making it suitable for point-of-care (POC) diagnostics, particularly in resource-limited settings. These methods include loop-mediated isothermal amplification (LAMP), nucleic acid sequence-based amplification (NASBA), strand displacement amplification (SDA), rolling circle amplification (RCA), and recombinase polymerase amplification (RPA). Additionally, it has several advantages, such as miniaturized sensors, in situ diagnosis, and compatibility with the World Health Organization's ASSURED criteria, making them highly valuable for rapid and accurate molecular diagnostics.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/isothermal-nucleic-acid-amplification-technology-market/requestsample

Isothermal Nucleic Acid Amplification Technology Market Trends and Drivers:

The global isothermal nucleic acid amplification technology market is primarily driven by the increasing demand for rapid and accurate molecular diagnostics. Isothermal amplification methods offer substantial advantages over traditional PCR, such as the ability to amplify nucleic acids at a constant temperature, eliminating the need for expensive thermal cyclers and complex laboratory setups, making it attractive in developing countries with limited resources and infrastructure for sophisticated molecular diagnostics. Moreover, the rising prevalence of infectious diseases, including viral, bacterial, and parasitic infections, is driving the demand for efficient and accessible diagnostic tools, representing another major growth-inducing factor. Also, isothermal nucleic acid amplification methods have shown great potential in the detection of infectious pathogens, enabling timely and accurate diagnosis and augmenting market growth. These methods are highly sensitive and specific, allowing for the detection of low-copy number targets with minimal false-positive or false-negative results. Along with this, the ability to perform rapid on-site diagnostics using isothermal amplification technology enhances patient management, infection control, and disease surveillance, propelling the market growth. Furthermore, the growing emphasis on personalized medicine and precision diagnostics is escalating the demand for advanced molecular technologies, enabling the detection of specific genetic variations or mutations associated with various diseases and creating a positive market outlook.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

  • Instruments
  • Reagents

Reagents hold the majority of theglobal isothermal nucleic acid amplification technology market sharedue to their increasing use in therapeutics.

Breakup by Technology:

  • Helicase-Dependent Amplification (HDA)
  • Nicking Enzyme Amplification Reaction (NEAR)
  • Loop-Mediated Isothermal Amplification (LAMP)
  • Strand Displacement Amplification (SDA)
  • Nucleic Acid Sequence-Based Amplification (NASBA)
  • Transcription Mediated Amplification (TMA)
  • Single Primer Isothermal Amplification (SPIA)
  • Others

TMA accounts for the majority of the total market share as it allows a clinical laboratory to perform nucleic acid test (NAT) assays for blood screening with fewer steps and less processing time.

Breakup by Application:

  • Infectious Disease Diagnosis
    • Hepatitis
    • CT/NG
    • HIV
    • Influenza
    • Others
  • Blood Screening
  • Others

Infectious disease diagnosis currently dominates the market due to the rising prevalence of infectious diseases across the globe.

Breakup by End-User:

  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories
  • Others

Hospitals presently dominate the market due to the increasing number of hospitals and significant development in the healthcare industry.

Breakup by Application:

  • Transportation Management
  • Inventory and Warehouse Management
  • Sourcing and Procurement Management
  • Order Management
  • Demand and Operations Planning
  • Others

Breakup by Vertical:

  • Consumer Goods and Retail
  • Food and Beverages
  • Healthcare and Life Sciences
  • Manufacturing
  • Transportation and Logistics
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Abbott Laboratories
  • bioMérieux SA
  • Becton
  • Dickinson and Company
  • Eiken Chemical Co. Ltd.
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • OptiGene Limited
  • Thermo Fisher Scientific Inc.
  • Tecan Trading AG
  • Ustar Biotechnologies Ltd.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: --

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163

MENAFN12022024004122016232ID1107839892


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.